IMCC IM Cannabis Corp.
USHealthcareAs of 2026-10-09 11:29
Why IMCC matters now
IM Cannabis Corp. (IMCC) is a US stock in Healthcare. The latest InvestLog snapshot shows $1.58 with -8.14% on the session and $954.2K in market capitalization; recent performance reads 1-month -18.90% and YTD -86.97%.
The latest financial table shown here is Q1 2026, with revenue of $6.3M, net income of $-1.7M, and EPS of $-279.98. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -1.4%.
The latest indexable market news headline is "IM Cannabis Announces Closing of the Sale of IMC Holdings and Its European-Focused Operations, Strengthens Balance Sheet" from PRNewsWire.
Additional event context on this page matters because analyst consensus is Hold with a median target of $—. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
4.72
P/S
0.45
EV/EBITDA
-80.47
DCF Value
$-11.98
FCF Yield
-1.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
24.8%
Operating Margin
-51.6%
Net Margin
-3.0%
ROE
-24.4%
ROA
-2.8%
ROIC
-95.0%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $6.3M | $-1.7M | $-279.98 |
| Q4 2025 | $11.2M | $-5.5M | $-1.28 |
| FY 2025 | $54.7M | $-11.3M | $-2.67 |
| Q3 2025 | $13.9M | $-3.7M | $-0.75 |
Analyst Ratings
Consensus
Hold
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
IL
Exchange
—
Beta
1.98
IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.